What's in Deseret Biologicals, Inc.'s pipeline?

Deseret Biologicals, Inc. has 4 drugs in our index: 4 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Deseret Biologicals, Inc.'s portfolio?

Top competitors by shared drug class: , B Braun, Chattem, Donat R. Spahn, Dr. Laurence Klotz.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/deseret-biologicals-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Deseret Biologicals, Inc. — Portfolio Competitive Intelligence Brief

Deseret Biologicals, Inc. pipeline: 4 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

4 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Area
Shame	SEROTONIN	marketed	Non-Standardized Fungal Allergenic Extract [EPC]	Neuroscience
Pollutox	OZONE	marketed	Radiographic Contrast Agent [EPC]	Other
Addiclenz	ASPARTAME	marketed	Standardized Chemical Allergen [EPC]	Immunology
Aspartame/MSG Detox	MALTODEXTRIN	marketed	Standardized Chemical Allergen [EPC]	Pain

Therapeutic area mix

Immunology · 1
Neuroscience · 1
Other · 1
Pain · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

· 2 shared drug classes
B Braun · 1 shared drug class
Chattem · 1 shared drug class
Donat R. Spahn · 1 shared drug class
Dr. Laurence Klotz · 1 shared drug class
GE HealthCare · 1 shared drug class
Liebel-Flarsheim · 1 shared drug class
Marjan Industria e Comercio ltda · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Deseret Biologicals, Inc.:

Cite this brief

Drug Landscape (2026). Deseret Biologicals, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/deseret-biologicals-inc. Accessed 2026-05-16.